Cytokinetics: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Tuesday reported a loss of $136.9 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.38.

The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for a loss of $1.03 per share.

The biopharmaceutical company posted revenue of $1.7 million in the period, also falling short of Street forecasts. Seven analysts surveyed by Zacks expected $9.5 million.

For the year, the company reported a loss of $526.2 million, or $5.45 per share. Revenue was reported as $7.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK

Advertisement

Recommended Stories